Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Rafia Bhore, PhD

Regeneron Pharmaceuticals, Inc.

Disclosure(s): Regeneron Pharmaceuticals, Inc.: Employement, Stocks/Bonds

Poster(s):

1079 - Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET